carbamylhydrazine has been researched along with Glucose Intolerance in 1 studies
carbamylhydrazine: RN given refers to parent cpd
Glucose Intolerance: A pathological state in which BLOOD GLUCOSE level is less than approximately 140 mg/100 ml of PLASMA at fasting, and above approximately 200 mg/100 ml plasma at 30-, 60-, or 90-minute during a GLUCOSE TOLERANCE TEST. This condition is seen frequently in DIABETES MELLITUS, but also occurs with other diseases and MALNUTRITION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Here we examined whether acute and chronic administration of benzylamine and vanadate in vivo enhances glucose tolerance and reduces hyperglycemia in diabetic rats." | 5.31 | Combined treatment with benzylamine and low dosages of vanadate enhances glucose tolerance and reduces hyperglycemia in streptozotocin-induced diabetic rats. ( Abella, A; Carpéné, C; Marti, L; Palacín, M; Testar, X; Zorzano, A, 2001) |
| " Here we examined whether acute and chronic administration of benzylamine and vanadate in vivo enhances glucose tolerance and reduces hyperglycemia in diabetic rats." | 1.31 | Combined treatment with benzylamine and low dosages of vanadate enhances glucose tolerance and reduces hyperglycemia in streptozotocin-induced diabetic rats. ( Abella, A; Carpéné, C; Marti, L; Palacín, M; Testar, X; Zorzano, A, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marti, L | 1 |
| Abella, A | 1 |
| Carpéné, C | 1 |
| Palacín, M | 1 |
| Testar, X | 1 |
| Zorzano, A | 1 |
1 other study available for carbamylhydrazine and Glucose Intolerance
| Article | Year |
|---|---|
Combined treatment with benzylamine and low dosages of vanadate enhances glucose tolerance and reduces hyperglycemia in streptozotocin-induced diabetic rats.
Topics: Adipocytes; Animals; Benzylamines; Biological Transport; Diabetes Mellitus, Experimental; Dose-Respo | 2001 |